Cite
HARVARD Citation
Plasse, T. et al. (2023). A randomized, placebo-controlled pilot study of upamostat, a host-directed serine protease inhibitor, for outpatient treatment of COVID-19. International journal of infectious diseases. pp. 148-156. [Online].